Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender WomenLinda‐Gail Bekker, Flavia Matovu Kiweewa, Katherine Gill et al.|New England Journal of Medicine|2024Cited by 471
Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South AfricaLeila E. Mansoor, Quarraisha Abdool Karim, Lara Lewis et al.|Journal of the International AIDS Society|2022Cited by 29
Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in WomenClaudia Juliette Jansen van Vuuren, Leila E. Mansoor, Lara Lewis et al.|AIDS and Behavior|2023Cited by 6